Mondaq All Regions - Brazil: Food, Drugs, Healthcare, Life Sciences
KLA
The Drugs Market Regulation Chamber (CMED) opened yesterday, September 13, 2017, a public consultation regarding resolution proposed...
Licks Attorneys
Once again, the Ministry of Health (MoH) changes the market share of PDPs involving monoclonal antibodies and etanercept.
Licks Attorneys
The list of proposals shows a substantial participation of both Brazilian-based and big pharma companies.
Clarke, Modet & Co
Since November 17, 2015, when the new Biodiversity Law (#13123/2015) went into force, the proposed online data base to facilitate the registration of access to the Brazilian genetic heritage and associated traditional knowledge was not yet implemented.
Clarke, Modet & Co
Desde 17 de novembro de 2015, quando entrou em vigor a nova Lei de Biodiversidade (nº 13123/2015), a base de dados online proposta para facilitar o registro do acesso ao patrimônio genético brasileiro e aos conhecimentos tradicionais associados ainda não havia sido implementada.
Ropes & Gray LLP
In recent years, there has been a spike in right-to-health litigation in Brazil wherein citizens seek court orders mandating that certain medications be dispensed through the public health system (Sistema Único de Saúde—"SUS").
TozziniFreire Advogados
On November 23 2016 the Health Surveillance Agency (ANVISA) approved changes to its rules for using substances subject to special control in order to provide easier access to drugs containing cannabidiol...
TozziniFreire Advogados
On November 23 2016 the Health Surveillance Agency (ANVISA) approved changes to its rules for using substances subject to special control in order to provide easier access to drugs containing CBD...
Moeller IP Advisors
On March 22, 2016, the Brazilian Health Authority (ANVISA) approved the amendments of Regulation RDC 48/2009, which refers to the post-approval changes of drug products.
Moeller IP Advisors
The Brazilian National Health Surveillance Authority (Anvisa) signed a cooperation project with the Republic of El Salvador through the local regulatory agency for medicine...
Moeller IP Advisors
According to an analysis of data from the Brazilian Health Surveillance Agency performed the Medical Device Consulting EMERGO, Brazilian regulators for the medical device market have reduced timeframes in 2015...
Moeller IP Advisors
According to the recent statistics released by the Brazilian Health Surveillance Agency (ANVISA), 742 medicines were registered in Brazil in 2015, a 105 percent overall increase over 2014.
OlarteMoure & Asociados LTDA
The decree regulates how the law should be applied and identifies principal problems in the access to genetic resources.
TozziniFreire Advogados
The Brazilian National Sanitary Surveillance Agency (ANVISA) published Resolution No. 102 issuing new rules for the transfer of marketing authorizations of cosmetic, drug, tobacco, agrochemicals and health products...
Trench Rossi Watanabe Advogados
The National Health of Surveillance Agency ("ANVISA") published today the Resolution RDC No 102/2016, authorizing the transfer of the registration ownership for products subject to sanitary surveillance due to corporate transactions (merger, spin-off and amalgamation) and to commercial transactions (asset deals).
L O Baptista Advogados
Resolution RDC No. 40/2015 of the Brazilian health surveillance agency (ANVISA), published in the federal gazette (DOU) on August 27, 2015, introduced important changes to the record (cadastro) of health products...
Licks Attorneys
Bill (PL) 200/2015 was proposed by the senate on April 07, 2015 and has raised an intense debate within the Brazilian Scientific Community.
Mattos Filho, Veiga Filho, Marrey Jr. e Quiroga Advogados
Federal Law No. 13,123/2015 came into force on November 17, 2015 introducing innovations for scientific research and technological development with respect to access to genetic heritage and associated traditional knowledge.
Mattos Filho, Veiga Filho, Marrey Jr. e Quiroga Advogados
Empresas das indústrias de fármacos, alimentos, cosméticos, biotecnologia e insumos agrícolas podem estar sujeitas a essa legislação.
DANIEL Legal & IP Strategy
The National Health Surveillance Agency (ANVISA) recently rejected a request for a Certificate of Good Manufacturing Practices from Brazil's largest pharmaceutical company-EMS.
Most Popular Recent Articles
Licks Attorneys
The list of proposals shows a substantial participation of both Brazilian-based and big pharma companies.
Licks Attorneys
Once again, the Ministry of Health (MoH) changes the market share of PDPs involving monoclonal antibodies and etanercept.
KLA
The Drugs Market Regulation Chamber (CMED) opened yesterday, September 13, 2017, a public consultation regarding resolution proposed...
TozziniFreire Advogados
On November 23 2016 the Health Surveillance Agency (ANVISA) approved changes to its rules for using substances subject to special control in order to provide easier access to drugs containing CBD...
Mattos Filho, Veiga Filho, Marrey Jr. e Quiroga Advogados
Federal Law No. 13,123/2015 came into force on November 17, 2015 introducing innovations for scientific research and technological development with respect to access to genetic heritage and associated traditional knowledge.
Moeller IP Advisors
On March 22, 2016, the Brazilian Health Authority (ANVISA) approved the amendments of Regulation RDC 48/2009, which refers to the post-approval changes of drug products.
L O Baptista Advogados
Resolution RDC No. 40/2015 of the Brazilian health surveillance agency (ANVISA), published in the federal gazette (DOU) on August 27, 2015, introduced important changes to the record (cadastro) of health products...
Licks Attorneys
Bill (PL) 200/2015 was proposed by the senate on April 07, 2015 and has raised an intense debate within the Brazilian Scientific Community.
Clarke, Modet & Co
Since November 17, 2015, when the new Biodiversity Law (#13123/2015) went into force, the proposed online data base to facilitate the registration of access to the Brazilian genetic heritage and associated traditional knowledge was not yet implemented.
Trench Rossi Watanabe Advogados
The National Health of Surveillance Agency ("ANVISA") published today the Resolution RDC No 102/2016, authorizing the transfer of the registration ownership for products subject to sanitary surveillance due to corporate transactions (merger, spin-off and amalgamation) and to commercial transactions (asset deals).
Clarke, Modet & Co
Desde 17 de novembro de 2015, quando entrou em vigor a nova Lei de Biodiversidade (nº 13123/2015), a base de dados online proposta para facilitar o registro do acesso ao patrimônio genético brasileiro e aos conhecimentos tradicionais associados ainda não havia sido implementada.
DANIEL Legal & IP Strategy
The National Health Surveillance Agency (ANVISA) recently rejected a request for a Certificate of Good Manufacturing Practices from Brazil's largest pharmaceutical company-EMS.
Article Search Using Filters
Related Topics
Popular Authors
Popular Contributors
Up-coming Events Search
Tools
Font Size:
Translation
Channels
Mondaq on Twitter